Marijuana and aspirin have been used for millennia to treat a wide range of maladies including pain and 27 inflammation. Both cannabinoids, like marijuana, that exert anti-inflammatory action through stimulating 28 cannabinoid receptors, and cyclooxygenase (COX) inhibitors, like aspirin, that suppress pro-inflammatory 29 eicosanoid production have shown beneficial outcomes in mouse models of neurodegenerative diseases 30 and cancer. Both cannabinoids and COX inhibitors, however, have untoward effects that discourage their 31 chronic usage, including cognitive deficits and gastrointestinal toxicity, respectively. Recent studies have un-32 covered that the serine hydrolase monoacylglycerol lipase (MAGL) links the endocannabinoid and eicosanoid 33 systems together through hydrolysis of the endocannabinoid 2-arachidonoylglycerol (2-AG) to provide the 34 major arachidonic acid (AA) precursor pools for pro-inflammatory eicosanoid synthesis in specific tissues.
Cannabinoids and cyclooxygenase (COX) inhibitors have been 66 used therapeutically for centuries collectively to alleviate pain, fever, 67 inflammation, anxiety, depression, convulsions, and lack of appetite 68 (Di Marzo, 2006; Dinarello, 2010; Miner and Hoffhines, 2007) . Direct Fig. 1 . MAGL coordinately regulates multiple lipid signaling pathways. MAGL blockade leads to an accumulation of the endocannabinoid 2-AG to enhance signaling upon cannabinoid receptors CB1 and CB2. In certain tissues, such as the brain, liver, and lung, MAGL controls the primary AA precursor pool for pro-inflammatory prostaglandin production. Blocking MAGL thus leads to a variety of beneficial effects through either enhancing endocannabinoid signaling or suppressing eicosanoid production. In cancer, MAGL plays a distinct role in controlling global FFAs levels that serve as the building blocks for synthesis of pro-tumorigenic signaling lipids such as PGE2 and lysophosphatidic acid (LPA). Blocking MAGL in aggressive cancer cells leads to a reduction in FFAs and attenuated cancer cell pathogenicity.
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